You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Find links to third party education sites and view recorded
sessions from global RDN experts on the latest clinical data,
patient selection criteria and RDN procedure updates.
The expanding role of radiofrequency renal denervation to achieve BP targets
Sunday 25 June, 2023
11:30-12:30
Room: Yellow hall 1
Moderators: Roland Schmieder, Atul Pathak
Speakers: Konstantinos Tsioufis, Atul Pathak, Sofie Brouwers, Yaron Arbel
The expanding role of radiofrequency renal denervation to achieve BP targets
Friday 30 June, 2023
12:20-13:05
Moderator: Michael Boehm
Speakers: Felix Mahfoud, Michael Boehm
Renal denervation: a turning point in hypertension management
Saturday 26 August, 2023
10:15-11:00
Room: Bratislava
Moderator: Konstantinos Tsioufis, Dagmara Hering
Speakers: Roland Schmieder, Alejandro Sanchez, Atul Pathak
Innovations in device-based treatment for hypertension
Moderator: Andrew Sharp
Speakers: Rosa Maria Bruno, Felix Mahfoud, Atul Pathak, Flavio Ribichini
Medscape’s education platform helps physicians learn about recent data with innovative interventional technology that can help patients achieve blood pressure control as an alternative to, or in addition to, typical treatment plans that include anti-hypertensive medications and lifestyle modifcations. CME credits available.
Radcliffe offers CME courses and webinars exploring renal denervation, clinical data, and many other topics, featuring Prof. Stefano Taddei, Prof. Atul Pathak, Prof. Andrew Sharp, Prof. Roland Schmeider, and other distinguished faculty. CME credits available.
WONDR Medical regularly introduces training resources and a wide array of video content in multiple languages at RDN:NOW.
The American Heart Association (AHA) offers a hypertension professional education series with new learning modules added regularly. Content includes webinars, spotlight series and podcasts. CME credits available.
This American College of Cardiology (ACC) education initiative platform helps learners evaluate and select evidence-based interventions and contemporary approaches for the treatment and control of hypertension. CME credits available.
Content includes webinars, podcasts, certifed cases, quick tip videos, gamification, patient case quizzes, and interactive cases/lessons.
Totality of evidence for RF renal denervation
Totality of evidence on radiofrequency renal denervation
SPYRAL HTN-ON MED 3 year results
SPYRAL HTN-ON MED 3 year results
Can renal denervation reduce cardiovascular events?
Can renal denervation reduce cardiovascular events?
Real-world experience with renal denervation
Real-world experience with renal denervation
SPYRAL HTN-ON MED trial results
SPYRAL HTN-ON MED trial results
Renal denervation safety, durability and high-risk patients
Renal Denervation safety, durability and high-risk patients
The science behind RF renal denervation safety and durability: SORT overview 2022
The science behind RF renal denervation safety and durability: SORT Overview 2022
Renal denervation: the Nephrologist's perspective
ESC-EAPCI consensus statement patient selection
Patient selection case study: patients intolerant to medications
Patient selection case study: patients intolerant to medications
Patient perspectives on renal denervation
Patient perspectives on renal denervation
The multi-disciplinary approach to patient selection for renal denervation
The multi-disciplinary approach to patient selection for renal denervation
Patient selection case study: high CV risk patients
Patient selection case study: high CV risk patients
Renal denervation in a high-risk population: the Verona experience
Professor Flavio Ribichini reviews their single-center experience demonstrating safety and efficacy of radiofrequency renal denervation in a high-risk cohort, with specific focus on CKD patients.
Radiofrequency renal denervation procedure
Animation demonstrating the simple design of the Symplicity Spyral™ system and a description of the RF RDN procedure.
The science behind radiofrequency renal denervation
Brief explanation of the mechanism behind radiofrequency RDN and the pre-clinical and clinical evidence supporting the durability of the procedure.
Evolution of RF RDN technology and evidence
The evolution of radiofrequency renal denervation technology and evidence
See which types of patients could beneft from the Symplicity blood pressure procedure.
The Symplicity blood pressure procedure is supported by multiple clinical trials and a real-world patient registry.1-4
The Symplicity blood pressure procedure is changing how patients with hypertension can reduce their blood pressure.
Mahfoud F, Kandzari DE, Kario K, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. The Lancet. 2022;399:1401-1410.
Mahfoud F, Mancia G, Schmieder R, et al. Three-year safety and efficacy in the Global Symplicity Registry: Impact of antihypertensive medication burden on blood pressure reduction. Presented at PCR e-course 2020.
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet. 2020;395:1444-1451.
Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. The Lancet. 2018;391(10137):2346.
Sign up for updates about the Symplicity blood pressure procedure.
SubscribeRequest more information about the Symplicity blood pressure procedure.
Request infoConnect with a Medtronic representative.
Connect with rep